Guide to Drug Financing Mechanisms
(1998; 64 pages) [French] [Spanish]
Table of Contents
View the documentForeword
View the documentAcknowledgements
Open this folder and view contentsIntroduction
Open this folder and view contentsChapter 1. Selection
Open this folder and view contentsChapter 2. Procurement
Close this folderChapter 3. Distribution
Open this folder and view contentsObjective of distribution
Close this folderImproving distribution
View the documentReduce stock shortages
View the documentReduce distribution costs
View the documentThe method of delivery
View the documentThe role of the information system
Open this folder and view contentsFinancing of consumption
Open this folder and view contentsChapter 4. Prescribing
Open this folder and view contentsSummary: contributions and limitations of the economic approach
View the documentReferences
View the documentSelected WHO publications of related interest
View the documentBack cover
 

The role of the information system

The information required for the distribution process comprises that needed to select and quantify drugs, and enough technical data to ensure proper conservation of those drugs.

Those involved in distribution should know what drugs are authorized in the country, what drugs are authorized in the different categories of the health services, and what drugs are listed as vital and essential in the VEN classification. In turn, the health services must know what drugs are available in the pharmacies. This information is not always sufficiently widely disseminated. Lack of information can cause stock shortages or impressions of shortages if drugs that have not been distributed are prescribed or if drugs that have been distributed are not prescribed.

Calculating the quantities of drugs needed requires information at several levels. Skilled management of stock in a pharmacy depends on knowing the current balance and flows of stock issued in the past. It is therefore necessary to have the relevant information at the peripheral level. Data from the periphery cannot simply be regrouped at the central level. Many data will be missing and other considerations, such as modifications in treatment schedules or changes in pharmaceutical policy, need to be taken into consideration. Thus the central level must have its own information system that permits quantification. If there are depots at an intermediate level, that level must also have an information system.

to previous section to next section
 

Last updated: May 3, 2013